메뉴 건너뛰기




Volumn 29, Issue 12, 2010, Pages 1130-1132

Update on rotavirus trends and the importance of surveillance

Author keywords

rotavirus; rotavirus vaccines; surveillance for rotavirus

Indexed keywords

EPITOPE; LIVE VACCINE; PENTAVALENT ROTAVIRUS VACCINE; ROTAVIRUS VACCINE; UNCLASSIFIED DRUG;

EID: 78650349216     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181ff1eeb     Document Type: Article
Times cited : (4)

References (19)
  • 1
    • 45949098442 scopus 로고    scopus 로고
    • Delayed onset and diminished magnitude
    • Centers for Disease Control and Prevention (CDC)
    • Centers for Disease Control and Prevention (CDC). Delayed onset and diminished magnitude . Morb Mortal Wkly Rep. 2008;57:697-700.
    • (2008) Morb Mortal Wkly Rep , vol.57 , pp. 697-700
  • 2
    • 59449101337 scopus 로고    scopus 로고
    • Prevention of rotavirus gastroenteritis
    • Cortese MM, et al. Prevention of rotavirus gastroenteritis. MMWR Recomm Rep. 2009; 58:1-25.
    • (2009) MMWR Recomm Rep , vol.58 , pp. 1-25
    • Cortese, M.M.1
  • 3
    • 23944461107 scopus 로고    scopus 로고
    • Serotype diversity and reassort-ment
    • Gentsch JR, et al. Serotype diversity and reassort-ment. J Infect Dis. 2005;192(suppl 1):S146-S159.
    • (2005) J Infect Dis , vol.192 , Issue.SUPPL. 1
    • Gentsch, J.R.1
  • 4
    • 74749087711 scopus 로고    scopus 로고
    • Impact of rotavirus vaccination
    • Gentsch JR, et al. Impact of rotavirus vaccination. Future Microbiol. 2009;4:1231-1234.
    • (2009) Future Microbiol , vol.4 , pp. 1231-1234
    • Gentsch, J.R.1
  • 5
    • 78650338929 scopus 로고    scopus 로고
    • Rotavirus: Providing optimal protection
    • Marshall GS, et al. Rotavirus: providing optimal protection. Pediatr Infect Dis J. 2009;28:355-362.
    • (2009) Pediatr Infect Dis J , vol.28 , pp. 355-362
    • Marshall, G.S.1
  • 6
    • 30044438810 scopus 로고    scopus 로고
    • Safety and efficacy
    • Ruiz-Palacios GM, et al. Safety and efficacy. N Engl J Med. 2006;354:11-22.
    • (2006) N Engl J Med , vol.354 , pp. 11-22
    • Ruiz-Palacios, G.M.1
  • 7
    • 30044442208 scopus 로고    scopus 로고
    • Safety and efficacy
    • Vesikari T, et al. Safety and efficacy. N Engl J Med. 2006;354:23-33.
    • (2006) N Engl J Med , vol.354 , pp. 23-33
    • Vesikari, T.1
  • 8
    • 0013506525 scopus 로고    scopus 로고
    • Strategic Advisory Group of Experts (SAGE) Accessed September 9, 2010
    • Strategic Advisory Group of Experts (SAGE). WHO: weekly epidemiologic record 84. 2009. Available at: http://edmgr.ovid.com/pidj/accounts/ ifauth.htm. Accessed September 9, 2010.
    • (2009) WHO: Weekly Epidemiologic Record , vol.84
  • 9
    • 78650406181 scopus 로고    scopus 로고
    • Rotavirus Vaccine Program Accessed September 9, 2010
    • Rotavirus Vaccine Program. Rotavirus Vaccine Program. 2004 -2008. Available at: http:// edmgr.ovid.com/pidj/accounts/ifauth.htm. Accessed September 9, 2010.
    • Rotavirus Vaccine Program 2004-2008
  • 10
    • 78650356549 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention (CDC) March 10, 2010 Accessed September 9, 2010
    • Centers for Disease Control and Prevention (CDC). Global Rotavirus Surveillance. March 10, 2010. Available at: http://edmgr.ovid.com/pidj/ accounts/ifauth.htm. Accessed September 9, 2010.
    • Global Rotavirus Surveillance
  • 11
    • 11244302672 scopus 로고    scopus 로고
    • Global distribution of ro-tavirus serotypes/genotypes
    • Santos N, Hoshino Y. Global distribution of ro-tavirus serotypes/genotypes. Rev Med Virol. 2005;15:29-56.
    • (2005) Rev Med Virol , vol.15 , pp. 29-56
    • Santos, N.1    Hoshino, Y.2
  • 12
    • 72849128524 scopus 로고    scopus 로고
    • Burden of severe rotavirus
    • Soenarto Y, et al. Burden of severe rotavirus. J Infect Dis. 2009;200(suppl 1):S188-S194.
    • (2009) J Infect Dis , vol.200 , Issue.SUPPL. 1
    • Soenarto, Y.1
  • 13
    • 74749096213 scopus 로고    scopus 로고
    • Rotavirus disease and vaccination
    • Matthijnssens J, et al. Rotavirus disease and vaccination. Future Microbiol. 2009;4:1303-1316.
    • (2009) Future Microbiol , vol.4 , pp. 1303-1316
    • Matthijnssens, J.1
  • 14
    • 46249105109 scopus 로고    scopus 로고
    • Active, population-based surveillance
    • Payne DC, et al. Active, population-based surveillance. Pediatrics. 2008;122:1235-1243.
    • (2008) Pediatrics , vol.122 , pp. 1235-1243
    • Payne, D.C.1
  • 15
    • 74749099108 scopus 로고    scopus 로고
    • Australian Rotavirus Surveillance Program annual report, 2008/2009
    • Kirkwood CD, et al. Australian Rotavirus Surveillance Program annual report, 2008/2009. Commun Dis Intell. 2009;33:382-388.
    • (2009) Commun Dis Intell. , vol.33 , pp. 382-388
    • Kirkwood, C.D.1
  • 16
    • 77956055765 scopus 로고    scopus 로고
    • Efficacy of pentavalent rotavirus vaccine
    • Zaman K, et al. Efficacy of pentavalent rotavirus vaccine. Lancet. 2010;376:615-623.
    • (2010) Lancet , vol.376 , pp. 615-623
    • Zaman, K.1
  • 17
    • 70649109984 scopus 로고    scopus 로고
    • Incidence of rotavirus
    • Gurgel RG, et al. Incidence of rotavirus. Gas-troenterology. 2009;137:1970-1975.
    • (2009) Gas-troenterology , vol.137 , pp. 1970-1975
    • Gurgel, R.G.1
  • 18
    • 66449101933 scopus 로고    scopus 로고
    • Association between pentavalent rotavirus vaccine
    • Patel M, et al. Association between pentavalent rotavirus vaccine. JAMA. 2009;301:2243-2251.
    • (2009) JAMA , vol.301 , pp. 2243-2251
    • Patel, M.1
  • 19
    • 75449098835 scopus 로고    scopus 로고
    • Effect of human rotavirus vaccine
    • Madhi SA, et al. Effect of human rotavirus vaccine. N Engl J Med. 2010;362:289-298.
    • (2010) N Engl J Med. , vol.362 , pp. 289-298
    • Madhi, S.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.